STOCK TITAN

Insider plans Rule 144 sale of 5,780 APLS shares on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

David O. Watson has filed a notice of proposed sale of 5,780 shares of common stock under Rule 144. The shares are expected to be sold through Fidelity Brokerage Services LLC on or about 01/13/2026 on the NASDAQ exchange, with an indicated aggregate market value of $128,242.01 and 126,525,218 shares of this class outstanding.

The 5,780 shares to be sold were acquired on 01/12/2026 via restricted stock vesting from the issuer as compensation, with payment also dated 01/12/2026. Over the prior three months, Watson sold three blocks of 5,000 common shares each on 10/16/2025, 11/17/2025, and 12/16/2025, for gross proceeds of $126,100.00, $100,300.00, and $122,450.00, respectively.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many APLS common shares are planned for sale in this Rule 144 notice?

The notice covers a proposed sale of 5,780 shares of common stock, as listed in the securities information section.

How were the APLS shares in this Form 144 acquired?

The 5,780 shares to be sold were acquired on 01/12/2026 through restricted stock vesting from the issuer as compensation.

Through which broker and exchange will the APLS shares be sold?

The filing lists Fidelity Brokerage Services LLC as the broker, with the proposed sale on the NASDAQ exchange.

What is the aggregate market value of the APLS shares covered by this Form 144?

The 5,780 common shares subject to the planned sale have an indicated aggregate market value of $128,242.01.

How many APLS common shares are outstanding according to this filing?

The securities information table states that the number of common shares outstanding is 126,525,218.

What recent APLS share sales has David O. Watson reported in the past 3 months?

He reported three sales of 5,000 common shares each on 10/16/2025, 11/17/2025, and 12/16/2025, with gross proceeds of $126,100.00, $100,300.00, and $122,450.00, respectively.

Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.60B
106.62M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM